HER2 overexpression is mainly attributed to HER2 gene amplification and/or mutation, leading to the activation of signal pathways such as PI3K/Akt/mTOR and Ras/Raf/MAPK, which promote tumor cell growth, differentiation, proliferation and metastasis. Here, ERBB2 is linked to neoplasm.